Roche group registers Phase III UC trial, GA-AMD study; AD extension stays activeOct 30Weekly roundup, 7 itemsafimkibartastegolimab
Genentech gets two ROZLYTREK label updates; Roche's IMvigor011, forimtamig results standOct 2Weekly roundup, 13 itemsafimkibartatezolizumabUpdated